Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jing-shu Chi"'
Autor:
Peng Liu, Xiao-ran Xie, Hao Wu, Huan Li, Jing-shu Chi, Xiao-ming Liu, Ju Luo, Yu Tang, Can-xia Xu
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Mesenchymal stem cells (MSCs) are a new therapeutic strategy for inflammatory bowel disease (IBD), and their efficacy has been widely recognized. However, there are still some challenges in cell therapy, including stable cell passage, labora
Externí odkaz:
https://doaj.org/article/8b22657718334070a930aa8edf09bafb
Autor:
Rong Li, Ming Li, Lin-fang Zhang, Xiao-ming Liu, Ting-zi Hu, Xiu-Juan Xia, Jing-shu Chi, Xiao-xia Jiang, Can-xia Xu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 49, Iss 5, Pp 1959-1969 (2018)
Background/Aims: Primary splenic angiosarcoma is an aggressive malignancy originating from endothelial cells with a particularly poor outcome despite radical therapy. Owing to its extremely low incidence, available data for splenic angiosarcoma are l
Externí odkaz:
https://doaj.org/article/b3266d6536924bdfb82f7574fcbf57f8
Publikováno v:
World Journal of Meta-Analysis. 9:1-11
Inflammatory pseudotumor-like follicular dendritic cell sarcoma: Literature review of 67 cases
Autor:
Peng Liu, Xiao-ran Xie, Hao Wu, Huan Li, Jing-shu Chi, Xiao-ming Liu, Ju Luo, Yu Tang, Can-xia Xu
Publikováno v:
Digestive diseases and sciences.
Mesenchymal stem cells (MSCs) are a type of adult pluripotent stem cell that has anti-inflammatory and immunomodulatory effects, and whose conditioned medium (CM) has also been found to be effective. We used MSC and CM enemas to investigate their ame
Autor:
Linfang Zhang, Greg C. Flaker, Zhiheng Chen, Canxia Xu, Da Liu, Jing-Shu Chi, Hui Wang, Greg Petroski, De-Lin Tian, Hong Hao, Zhenguo Liu, Yixi Li, Rong Li, Xiaoming Liu, Huan Li, Xiujuan Xia
Publikováno v:
Atherosclerosis
Background and aims Atherosclerosis is an important contributing factor to cardiovascular mortality. The role of Helicobacter pylori (H. pylori) infection in atherosclerosis is inconsistent and sometimes controversial. The present study aimed to dete
Publikováno v:
World Journal of Gastroenterology
Helicobacter pylori (H. pylori) is a Gram-negative bacterium with a number of virulence factors, such as cytotoxin-associated gene A, vacuolating cytotoxin A, its pathogenicity island, and lipopolysaccharide, which cause gastrointestinal diseases. Co
Autor:
Xiu-Juan Xia, Jing-Shu Chi, Xiaoming Liu, Huan Li, Lin-Fang Zhang, Canxia Xu, Peng Liu, Hao Wu
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Helicobacter pylori infection is associated with various vascular diseases. However, its mechanism is yet to be defined. The present study aimed to investigate the effect of H. pylori on vascular endothelial cells as well as the GATA3-rela
Autor:
Huan Li, Jing-Shu Chi, Xiaoming Liu, De-Lin Tian, Linfang Zhang, Xiujuan Xia, Xiao-Ran Xie, Peng Liu, Kai-Xiao Kun, Ren-Jie Gong, Canxia Xu, Hao Wu
Publikováno v:
European journal of gastroenterologyhepatology. 32(2)
Background Bismuth has antimicrobial activity and can improve the efficacy of triple Helicobacter pylori (H. pylori) therapy. Allicin added to conventional therapy for H. pylori infection also improves H. pylori eradication rates. Thus, this study ai
Autor:
Duan-Fang Liao, Yuqi Cui, Da Liu, Li Rong, Yixi Li, Xiaoming Liu, Jing-Shu Chi, Hui Wang, Hong Hao, Xiujuan Xia, Tingzi Hu, Huan Li, Yinjie Guo, Canxia Xu, Xue Zhang, Linfang Zhang, Gregory C. Flaker, Zhenguo Liu, Xi-Long Zheng, Jin Cai
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Epidemiological studies have suggested an association between Helicobacter pylori ( H pylori ) infection and atherosclerosis through undefined mechanisms. Endothelial dysfunction is critical to the development of atherosclerosis and relate
Autor:
Lin-Fang Zhang, Xiao-Xia Jiang, Xiaoming Liu, Jing-Shu Chi, Canxia Xu, Xiu-Juan Xia, Rong Li, Ting-Zi Hu, Ming Li
Publikováno v:
Cellular Physiology and Biochemistry, Vol 49, Iss 5, Pp 1959-1969 (2018)
Background/Aims: Primary splenic angiosarcoma is an aggressive malignancy originating from endothelial cells with a particularly poor outcome despite radical therapy. Owing to its extremely low incidence, available data for splenic angiosarcoma are l